Chung-Pu Wu is an Assistant Professor of pharmacology at the Department of Physiology and Pharmacology, Chang Gung University, Tao-Yuan, Taiwan. He received his B.S. degree in chemistry and biochemistry, B.S. (Hons.) degree in pharmacology, and an M.S. degree in molecular biology from University of Cape Town, Cape Town, South Africa. He was offered a pre-CRTA position at the National Cancer Institute, NIH, USA in 2004 during his Ph.D. program, and subsequently received his Ph.D. degree in pharmacology from University of Cambridge, Cambridge, UK. Dr. Wu was awarded a postdoctoral fellowship from the Division of Biotechnology and Pharmaceutical Research, National Health Research Institute, Taiwan, to develop small molecule compound that blocks dengue virus replication, as well as identify the molecular mechanisms by which they interrupt the virus lifecycle. In 2006, he was offered a Visiting Fellow position at the Lab of Cell Biology, NCI, NIH, USA to characterize the mechanism of action of multidrug resistance-linked ABC transporters and examine the properties of cancer-initiating cells or cancer stem cells that are highly resistant to chemotherapy. His scientific interests concentrate on the development of high-throughput drug screening platforms, design and discover new chemotherapeutics, as well as study the mechanisms and circumvent drug resistance in various types of cancers.
Biography Updated on 28 May 2012